Business

Portfolio co Hinge Health completes $300m round

Portfolio co Hinge Health completes $300m round.

articleIp Group PlcJanuary 6, 20214/company/ip-group/news/portfolio-co-hinge-health-completes-dollar300m-round
Portfolio co Hinge Health completes $300m round

About this update from Ip Group Plc

[{"type":"text","content":"\n \n \n \n RNS Number : 8336K\n IP Group PLC\n 06 January 2021\n  \n \n \n \n \n \n \n FOR RELEASE ON\n \n \n \n \n 06 January 2021\n \n \n \n \n \n  \n \n \n THIS ANNOUNCEMENT CONSTITUTES INSIDE INFORMATION AS STIPULATED UNDER THE MARKET ABUSE REGULATION (EU) NO.596/2014.\n \n \n  \n \n \n IP Group plc - Portfolio company Hinge Health completes $300m funding round\n \n \n  \n \n \n IP Group plc (LSE: IPO) (\"IP Group\" or \"the Group\"), the developer of intellectual property-based businesses, notes that portfolio company Hinge Health, Inc, a \n digital clinic for back and joint pain for employers and health plans\n , h\n as \n completed a $300m (£225m*) Series D investment round valuing the company at approximately $3bn (£2.2bn*).\n \n \n  \n \n \n Following completion of the investment round, IP Group has an undiluted beneficial holding of approximately 2.4% in Hinge Health that the directors anticipate will be valued at £42.1 million, representing a \n net unrealised fair value gain to the Group of approximately £30.7 million.\n \n \n  \n \n \n * GBP equivalent using 1.34 USD/GBP\n \n \n  \n \n \n For more information, please contact:\n \n \n  \n \n \n \n \n \n IP Group plc\n \n \n \n \n \n www.ipgroupplc.com\n \n \n \n \n \n \n \n Greg Smith, Chief Financial Officer\nLiz Vaughan-Adams, Communications  \n \n \n \n \n +44 (0) 20 7444 0050\n+44 (0) 20 7444 0062/+44 (0) 7979 853802\n \n \n \n \n \n \n Charlotte Street Partners\n \n \n \n \n \n \n \n \n \n \n \n \n \n David Gaffney\n \n \n \n \n +44 (0) 7854 609998\n \n \n \n \n \n \n Andrew Wilson\n \n \n \n \n +44 (0) 7810 636995\n \n \n \n \n \n  \n \n \n Notes for editors\n \n \n  \n \n \n About IP Group\n \n \n  \n \n \n IP Group is a leading intellectual property commercialisation company which focuses on evolving great ideas, mainly from its partner universities, into world-changing businesses. The Group has pioneered a unique approach to developing these ideas and the resulting businesses by providing access to business building expertise, capital (through its 100%-owned FCA-authorised subsidiaries IP Capital and Parkwalk Advisors), networks, recruitment and business support. IP Group has a strong track record of success and its portfolio comprises holdings in early-stage to mature businesses across life scienc...

More updates from Ip Group Plc